Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA230796
Max Phase: Preclinical
Molecular Formula: C41H61N7O9
Molecular Weight: 795.98
Molecule Type: Small molecule
Associated Items:
ID: ALA230796
Max Phase: Preclinical
Molecular Formula: C41H61N7O9
Molecular Weight: 795.98
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1COC(=O)NC1CCCCC1)[C@@H](C)O
Standard InChI: InChI=1S/C41H61N7O9/c1-26(2)36(47-38(52)33(17-9-10-20-42)45-35(51)25-56-32-19-18-28-12-7-8-13-29(28)22-32)39(53)43-23-34(50)46-37(27(3)49)40(54)48-21-11-16-31(48)24-57-41(55)44-30-14-5-4-6-15-30/h7-8,12-13,18-19,22,26-27,30-31,33,36-37,49H,4-6,9-11,14-17,20-21,23-25,42H2,1-3H3,(H,43,53)(H,44,55)(H,45,51)(H,46,50)(H,47,52)/t27-,31+,33+,36+,37+/m1/s1
Standard InChI Key: MFTPPHGVFJWMSL-HXAQDDAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 795.98 | Molecular Weight (Monoisotopic): 795.4531 | AlogP: 2.00 | #Rotatable Bonds: 20 |
Polar Surface Area: 230.52 | Molecular Species: BASE | HBA: 10 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.63 | CX Basic pKa: 10.19 | CX LogP: 1.09 | CX LogD: -1.36 |
Aromatic Rings: 2 | Heavy Atoms: 57 | QED Weighted: 0.10 | Np Likeness Score: -0.45 |
1. Neffe AT, Bilang M, Grüneberg I, Meyer B.. (2007) Rational optimization of the binding affinity of CD4 targeting peptidomimetics with potential anti HIV activity., 50 (15): [PMID:17602545] [10.1021/jm070206b] |
Source(1):